| 1 |
Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 2002, 99(2): 507-512.
|
| 2 |
Greenberg PL, Lee SJ, Advani R, et al. Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refra ctory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995). J Clin Oncol, 2004, 22(6): 1078-1086.
|
| 3 |
Bao S, Wu Q, Roger E, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444(6): 756-760.
|
| 4 |
Yu F, Yao H, Zhu P, et al. let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell, 2007, 131(6): 1109-1123.
|
| 5 |
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988.
|
| 6 |
Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res, 2005, 65(14): 6207-6219.
|
| 7 |
Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 2005, 65(13): 5506-5511.
|
| 8 |
Zhou BB, Bartek J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nature Rev Cancer, 2004, 4(3): 216-225.
|
| 9 |
Laurent A, Nayanta S, Lan C, et al. CHK2 Kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nature Rev Cancer, 2007, 7(12): 925-936.
|
| 10 |
Chen Y, Sanchez Y. Chk1 in the DNA damage response: conserved roles from yeasts to mammals. DNA Repair, 2004, 3(8-9): 1025-1032.
|
| 11 |
Li J, Taylor IA, Lioyd J, et al. Chk2 oligomerization studied by phosphopeptide ligation: implications for regulation and phosphodependent interactions. J Biol Chem, 2008, 283(51): 36 019-36 130.
|
| 12 |
Olsen BB, Larsen MR, Boldyreff B, et al. Exploring the intramolecular phosphorylation sites in human Chk2. Mutat Res, 2008, 646(1-2): 50-59.
|
| 13 |
Huang M, Miao ZH, Zhu H, et al. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. Mol Cancer Ther, 2008, 7(6): 1440-1449.
|
| 14 |
Zhuang J, Zhang J, Willers H, et al. Checkpoint kinase 2 mediated hosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res, 2006, 66(3): 401-1408.
|
| 15 |
Reinhardt HC, Yaffe MB. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol, 2009, 21(2): 245-255.
|
| 16 |
Zhang W, Poh A, Fanous AA, et al. DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2. Cell Cycle, 2008, 7(11): 1668-1677.
|
| 17 |
Roos WP, Kaina B. Roos and Bernd Kaina. DNA damage-induced cell death by apoptosis. Trends Mol Med, 2006, 12(9): 440-450.
|